Children First. Lessons from Paediatric Research

In an industry moving towards patient-centricity, patient research is on the rise as pharmaceutical companies strive to develop a greater understanding of their product’s end users. However, this can be complicated if your end users are children.

Although research with children has its challenges, they are not insurmountable if you employ the right methodologies. Ipsos’s award winning ethnographic research with Pfizer demonstrated how children can add great value to research if conducted correctly, as we sought to understand how paediatric patients were affected by Growth Hormone Deficiency (GHD).

The research has enabled Pfizer to gain a deeper understanding of the emotional and psychological impact of the condition. Observing families and children have allowed Pfizer to see where challenges and unmet needs exist, and ultimately helped to inform them as to how they could improve the lives of GHD sufferers and their families.

Download our paper which showcases our award winning work.

If you have any questions or comments, please contact [email protected]

The author(s)

More insights about Health

Related news